Search research articles
Contact Us
Filters
Showing results (41-50 of 55) with videos related to
Page
of 6
Sort By:
Scandinavian Journal of Urology
|
December 12, 2018
Outcome of sentinel lymph node biopsy in patients with clinically non-metastatic renal cell carcinoma
Teele Kuusk, Roderick De Bruijn, Oscar R Brouwer, et al.
European Urology
|
March 21, 2025
European Association of Urology Guidelines on Renal Cell Carcinoma: The 2025 Update
Axel Bex, Yasmin Abu Ghanem, Laurence Albiges, et al.
European Urology
|
June 2, 2021
The 2021 Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Immune Checkpoint Inhibitor-based Combination Therapies for Treatment-naive Metastatic Clear-cell Renal Cell Carcinoma Are Standard of Care
Jens Bedke, Laurence Albiges, Umberto Capitanio, et al.
European Urology
|
November 26, 2022
European Association of Urology Guidelines Panel on Renal Cell Carcinoma Update on the New World Health Organization Classification of Kidney Tumours 2022: The Urologist's Point of View
Milan Hora, Laurence Albiges, Jens Bedke, et al.
European Urology
|
December 16, 2022
Reply to Yaxiong Tang, Xu Hu, Kan Wu, Yanxiang Shao, and Xiang Li's Letter to the Editor re: Umberto Capitanio, Jens Bedke, Laurence Albiges, et al. A Renewal of the TNM Staging System for Patients with Renal Cancer To Comply with Current Decision-making: Proposal from the European Association of Urology Guidelines Panel. Eur Urol. 2022;83:3-5
Umberto Capitanio, Jens Bedke, Laurence Albiges, et al.
European Urology
|
December 18, 2021
2021 Updated European Association of Urology Guidelines on the Use of Adjuvant Pembrolizumab for Renal Cell Carcinoma
Jens Bedke, Laurence Albiges, Umberto Capitanio, et al.
European Urology
|
December 28, 2020
Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Nivolumab plus Cabozantinib Joins Immune Checkpoint Inhibition Combination Therapies for Treatment-naïve Metastatic Clear-Cell Renal Cell Carcinoma
Jens Bedke, Laurence Albiges, Umberto Capitanio, et al.
European Urology
|
May 12, 2026
Management of Lymph Node-Positive Renal Cell Carcinoma: Updated Recommendations from the European Association of Urology Renal Cell Carcinoma Guidelines Panel
Umberto Capitanio, Patricia Zondervan, Riccardo Campi, et al.
European Urology
|
March 29, 2022
European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 Update
Börje Ljungberg, Laurence Albiges, Yasmin Abu-Ghanem, et al.
European Urology Oncology
|
April 5, 2020
Limitations of Available Studies Prevent Reliable Comparison Between Tumour Ablation and Partial Nephrectomy for Patients with Localised Renal Masses: A Systematic Review from the European Association of Urology Renal Cell Cancer Guideline Panel
Yasmin Abu-Ghanem, Sergio Fernández-Pello, Axel Bex, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 55) with videos related to
Sort By:
Page
of 6
Scandinavian Journal of Urology
|
December 12, 2018
Outcome of sentinel lymph node biopsy in patients with clinically non-metastatic renal cell carcinoma
Teele Kuusk, Roderick De Bruijn, Oscar R Brouwer, et al.
European Urology
|
March 21, 2025
European Association of Urology Guidelines on Renal Cell Carcinoma: The 2025 Update
Axel Bex, Yasmin Abu Ghanem, Laurence Albiges, et al.
European Urology
|
June 2, 2021
The 2021 Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Immune Checkpoint Inhibitor-based Combination Therapies for Treatment-naive Metastatic Clear-cell Renal Cell Carcinoma Are Standard of Care
Jens Bedke, Laurence Albiges, Umberto Capitanio, et al.
European Urology
|
November 26, 2022
European Association of Urology Guidelines Panel on Renal Cell Carcinoma Update on the New World Health Organization Classification of Kidney Tumours 2022: The Urologist's Point of View
Milan Hora, Laurence Albiges, Jens Bedke, et al.
European Urology
|
December 16, 2022
Reply to Yaxiong Tang, Xu Hu, Kan Wu, Yanxiang Shao, and Xiang Li's Letter to the Editor re: Umberto Capitanio, Jens Bedke, Laurence Albiges, et al. A Renewal of the TNM Staging System for Patients with Renal Cancer To Comply with Current Decision-making: Proposal from the European Association of Urology Guidelines Panel. Eur Urol. 2022;83:3-5
Umberto Capitanio, Jens Bedke, Laurence Albiges, et al.
European Urology
|
December 18, 2021
2021 Updated European Association of Urology Guidelines on the Use of Adjuvant Pembrolizumab for Renal Cell Carcinoma
Jens Bedke, Laurence Albiges, Umberto Capitanio, et al.
European Urology
|
December 28, 2020
Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Nivolumab plus Cabozantinib Joins Immune Checkpoint Inhibition Combination Therapies for Treatment-naïve Metastatic Clear-Cell Renal Cell Carcinoma
Jens Bedke, Laurence Albiges, Umberto Capitanio, et al.
European Urology
|
May 12, 2026
Management of Lymph Node-Positive Renal Cell Carcinoma: Updated Recommendations from the European Association of Urology Renal Cell Carcinoma Guidelines Panel
Umberto Capitanio, Patricia Zondervan, Riccardo Campi, et al.
European Urology
|
March 29, 2022
European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 Update
Börje Ljungberg, Laurence Albiges, Yasmin Abu-Ghanem, et al.
European Urology Oncology
|
April 5, 2020
Limitations of Available Studies Prevent Reliable Comparison Between Tumour Ablation and Partial Nephrectomy for Patients with Localised Renal Masses: A Systematic Review from the European Association of Urology Renal Cell Cancer Guideline Panel
Yasmin Abu-Ghanem, Sergio Fernández-Pello, Axel Bex, et al.
Page
of 6